| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 662034 | 70420 | IODURO (123 I) DE SODIO CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE | IODURO (123 I) DE SODIO CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE , 1 vial de 74 MBq en fecha y hora de calibración | 37 MBq/ml | 45 | 1 | 34 | 1 vial de 74 MBq en fecha y hora de calibración | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70420/70420_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70420/70420_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28969 | CURIUM PHARMA SPAIN S.A. | 2009-01-19 | 1 | 1 | 1 | 2009-01-30 | 2009-01-19 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 662035 | 70420 | IODURO (123 I) DE SODIO CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE | IODURO (123 I) DE SODIO CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE , 1 vial de 185 MBq en fecha y hora de calibración | 37 MBq/ml | 45 | 1 | 34 | 1 vial de 185 MBq en fecha y hora de calibración | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70420/70420_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70420/70420_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28969 | CURIUM PHARMA SPAIN S.A. | 2009-01-19 | 1 | 1 | 1 | 2009-01-30 | 2009-01-19 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 662036 | 70420 | IODURO (123 I) DE SODIO CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE | IODURO (123 I) DE SODIO CURIUM PHARMA SPAIN 37 MBq/ml SOLUCION INYECTABLE , 1 vial de 370 MBq en fecha y hora de calibración | 37 MBq/ml | 45 | 1 | 34 | 1 vial de 370 MBq en fecha y hora de calibración | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70420/70420_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70420/70420_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28969 | CURIUM PHARMA SPAIN S.A. | 2009-01-19 | 1 | 1 | 1 | 2009-01-30 | 2009-01-19 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 662182 | 70427 | IODURO (I131) DE SODIO CURIUM PHARMA SPAIN 37-7400 MBq CAPSULAS | IODURO (I131) DE SODIO CURIUM PHARMA SPAIN 37-7400 MBq CAPSULAS , 1 cápsula | 37 - 7.400 MBq | 45 | 1 | 43 | 1 cápsula | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70427/70427_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70427/70427_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28969 | CURIUM PHARMA SPAIN S.A. | 2009-01-30 | 1 | 1 | 1 | 2009-01-30 | 2009-01-30 | 1 | 2011-10-05 | View Edit Delete | ||||||||||||
| 663528 | 71081 | STAMICIS 1 mg EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA EFG | STAMICIS 1 mg EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA EFG, 5 viales | 1 mg | 45 | 5 | 34 | 5 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71081/71081_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71081/71081_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | CURIUM PHARMA SPAIN S.A. | 2009-06-26 | 1 | 1 | 1 | 2009-06-26 | 2009-06-26 | 1 | 2012-04-17 | View Edit Delete | ||||||||||||
| 662133 | 08494001 | STELARA 45 mg SOLUCION INYECTABLE | STELARA 45 mg SOLUCION INYECTABLE, 1 vial de 0,5 ml | 45 mg | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08494001/08494001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08494001/08494001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | JANSSEN CILAG S.A. | 2009-02-04 | 1 | 1 | 1 | 2009-02-04 | 2009-02-04 | 1 | 2015-11-10 | View Edit Delete | ||||||||||||
| 662353 | 61972 | TRIALONA ACCUHALER 500 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN | TRIALONA ACCUHALER 500 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN, 1 inhalador de 60 dosis | 500 microgramos/dosis | 46 | 60 | 8 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61972/61972_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61972/61972_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1998-04-01 | 1 | 1 | 1 | 1998-04-01 | 1998-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 662361 | 61971 | TRIALONA ACCUHALER 100 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN | TRIALONA ACCUHALER 100 MICROGRAMOS/INHALACIÓN, POLVO PARA INHALACIÓN, 1 inhalador de 60 dosis | 100 microgramos/dosis | 46 | 60 | 8 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61971/61971_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61971/61971_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1998-04-01 | 1 | 1 | 1 | 1998-04-01 | 1998-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 662794 | 70803 | RHINOVIN DUO 0,5 mg/ml + 0.6 mg/ml SOLUCION PARA PULVERIZACION NASAL | RHINOVIN DUO 0,5 mg/ml + 0.6 mg/ml SOLUCION PARA PULVERIZACION NASAL, 1 envase pulverizador de 10 ml (pulsador vertical) | 0,6 mg/ml + 0,5 mg/ml | 65 | 10 | 26 | 1 envase pulverizador de 10 ml (pulsador vertical) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70803/70803_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70803/70803_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71217 | HALEON SPAIN S.A. | 2009-04-07 | 1 | 1 | 1 | 2009-04-07 | 2009-04-07 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 663133 | 99126020 | ENBREL 50 mg SOLUCION INYECTABLE EN PLUMAS PRECARGADAS | ENBREL 50 mg SOLUCION INYECTABLE EN PLUMAS PRECARGADAS, 4 plumas precargadas de 1 ml | 50 mg inyectable 1 ml | 66 | 4 | 49 | 4 plumas precargadas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99126020/99126020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99126020/99126020_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2009-09-17 | 1 | 1 | 1 | 2009-09-17 | 2009-09-17 | 1 | 2011-05-09 | View Edit Delete | ||||||||||||
| 662920 | 70804 | FELIBEN 35 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 35 microgramos/HORA PARCHES TRANSDERMICOS. , 5 parches | 35 microgramos/h | 74 | 5 | 28 | 5 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70804/70804_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70804/70804_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-13 | 1 | 1 | 1 | 2009-05-13 | 2009-05-13 | 0 | 2012-01-13 | Lista III | View Edit Delete | |||||||||||
| 662922 | 70804 | FELIBEN 35 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 35 microgramos/HORA PARCHES TRANSDERMICOS. , 10 parches | 35 microgramos/h | 74 | 10 | 28 | 10 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70804/70804_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70804/70804_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-13 | 1 | 1 | 1 | 2009-05-13 | 2009-05-13 | 0 | 2015-11-11 | Lista III | View Edit Delete | |||||||||||
| 662935 | 70805 | FELIBEN 52,5 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 52,5 microgramos/HORA PARCHES TRANSDERMICOS. , 5 parches | 52,5 microgramos/h | 74 | 5 | 28 | 5 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70805/70805_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70805/70805_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-12 | 1 | 1 | 1 | 2009-05-12 | 2009-05-12 | 0 | 2012-01-13 | Lista III | View Edit Delete | |||||||||||
| 662937 | 70805 | FELIBEN 52,5 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 52,5 microgramos/HORA PARCHES TRANSDERMICOS. , 10 parches | 52,5 microgramos/h | 74 | 10 | 28 | 10 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70805/70805_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70805/70805_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-12 | 1 | 1 | 1 | 2009-05-12 | 2009-05-12 | 0 | 2015-11-11 | Lista III | View Edit Delete | |||||||||||
| 662948 | 70806 | FELIBEN 70 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 70 microgramos/HORA PARCHES TRANSDERMICOS. , 5 parches | 70 microgramos/h | 74 | 5 | 28 | 5 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70806/70806_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70806/70806_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-13 | 1 | 1 | 1 | 2009-05-13 | 2009-05-13 | 0 | 2012-01-13 | Lista III | View Edit Delete | |||||||||||
| 662950 | 70806 | FELIBEN 70 microgramos/HORA PARCHES TRANSDERMICOS. | FELIBEN 70 microgramos/HORA PARCHES TRANSDERMICOS. , 10 parches | 70 microgramos/h | 74 | 10 | 28 | 10 parches | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70806/70806_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70806/70806_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10255 | LABORATORIOS GEBRO PHARMA S.A. | 2009-05-13 | 1 | 1 | 1 | 2009-05-13 | 2009-05-13 | 0 | 2015-11-11 | Lista III | View Edit Delete | |||||||||||
| 662577 | 61961 | DUROGESIC MATRIX 100 microgramos/H PARCHES TRANSDERMICOS | DUROGESIC MATRIX 100 microgramos/H PARCHES TRANSDERMICOS , 5 parches | 100 microgramos/h | 74 | 5 | 28 | 5 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61961/61961_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61961/61961_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71027 | JANSSEN CILAG S.A. | 1998-03-01 | 1 | 1 | 1 | 1998-03-01 | 1998-03-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 662585 | 61960 | DUROGESIC MATRIX 50 microgramos/H PARCHES TRANSDERMICOS | DUROGESIC MATRIX 50 microgramos/H PARCHES TRANSDERMICOS , 5 parches | 50 microgramos/h | 74 | 5 | 28 | 5 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61960/61960_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61960/61960_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71027 | JANSSEN CILAG S.A. | 1998-03-01 | 1 | 1 | 1 | 1998-03-01 | 1998-03-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 662593 | 61959 | DUROGESIC MATRIX 25 microgramos/H PARCHES TRANSDERMICOS | DUROGESIC MATRIX 25 microgramos/H PARCHES TRANSDERMICOS , 5 parches | 25 microgramos/h | 74 | 5 | 28 | 5 parches | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61959/61959_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61959/61959_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71027 | JANSSEN CILAG S.A. | 1998-03-01 | 1 | 1 | 1 | 1998-03-01 | 1998-03-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 663025 | 26269 | ATARAX 2 mg/ml JARABE | ATARAX 2 mg/ml JARABE , 1 frasco de 150 ml | 2 mg/ml | 88 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/26269/26269_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/26269/26269_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21333 | UCB PHARMA S.A. | 1956-07-01 | 1 | 1 | 1 | 1956-07-01 | 2009-05-18 | 1 | 2011-05-04 | View Edit Delete |
Page 200 of 1036, showing 20 records out of 20704 total, starting on record 3981, ending on 4000